Table of Contents 2
List of Tables 4
List of Figures 5
Lupin Limited Spshot 6
Lupin Limited Overview 6
Key Information 6
Key Facts 6
Lupin Limited - Research and Development Overview 7
Key Therapeutic Areas 7
Lupin Limited - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Lupin Limited - Pipeline Products Glance 12
Lupin Limited - Late Stage Pipeline Products 12
Phase III Products/Combition Treatment Modalities 12
Lupin Limited - Clinical Stage Pipeline Products 13
Phase II Products/Combition Treatment Modalities 13
Phase I Products/Combition Treatment Modalities 14
Lupin Limited - Early Stage Pipeline Products 15
Preclinical Products/Combition Treatment Modalities 15
Discovery Products/Combition Treatment Modalities 16
Lupin Limited - Unknown Stage Pipeline Products 17
Unknown Products/Combition Treatment Modalities 17
Lupin Limited - Drug Profiles 18
Biosimilar for Oncology 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
etanercept biosimilar 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
LND-101001 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
LNP-1892 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Small Molecule for Colon and Lung Cancer 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Small Molecule to Agonize CaSR for Chronic Kidney Disease and Primary Hyperparathyroidism 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Biosimilar for Diabetes 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Biosimilar for Inflammation 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Biosimilar for Ophthalmology 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Biosimilar for Viral Infections 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Small Molecule for Autoimmune Diseases 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Small Molecule for Infectious Diseases 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Small Molecule for Pain and Inflammation 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Biosimilar for Endocrinology 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Lupin Limited - Pipeline Alysis 32
Lupin Limited - Pipeline Products by Target 32
Lupin Limited - Pipeline Products by Route of Administration 33
Lupin Limited - Pipeline Products by Molecule Type 34
Lupin Limited - Pipeline Products by Mechanism of Action 35
Lupin Limited - Recent Pipeline Updates 36
Lupin Limited - Dormant Projects 37
Lupin Limited - Company Statement 38
Lupin Limited - Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Appendix 43
Methodology 43
Coverage 43
Secondary Research 43
Primary Research 43
Expert Panel Validation 43
Contact Us 43
Disclaimer 44